All News
ALZForum: PrevenTRON and Beyond
24 Jul 2026 Part 2 of 2No, they are not Optimus Jr, Megatron’s clones, or any other new, amyloid-shattering members of the Tron family franchise of transformer robots, though perhaps Roche does not mind if you think so for a moment. Rather, the TRONTIER twins are currently enrolling Phase 3 trials for early AD, and […]
PR Newswire: Cumulus Neuroscience Presents Data at AAIC 2026 Annual Meeting Showing a Two-Minute Digital Task Matches or Outperforms Clinical Benchmarks for Alzheimer’s Trial Pre-enrichment
Across three independent studies, the NeuLogiq® Platform two-minute tablet-based Symbol Swap task delivered clinically meaningful discrimination between control, MCI and Alzheimer’s dementia groups and detected blood-biomarker-defined pathology — including in clinically normal individuals — with accuracy matching or exceeding the ADAS-Cog, MoCA and MMSE benchmarks. LONDON, July 15, 2026 /PRNewswire/ — Cumulus Neuroscience (Cumulus; The Company), a global […]
Tech Times: Tablet Task Beats Alzheimer’s Clinical Tests in Two Minutes, AAIC Data Show
Symbol Swap matched or exceeded ADAS-Cog, MoCA, and MMSE across three independent studiesBy Henry BakerPublished: Jul 15 2026, 3:39 PM EDT On the final day of the world’s largest dementia research conference, a startup presented data Wednesday suggesting that a two-minute tablet task can do what a trained clinician typically takes 10 to 45 minutes to […]
Nguoi Viet News: Hundreds of residents attended a free health fair at St. Columban Church.
July 1, 2026 The Nguoit Viet News wrote an article in Vietnamese on how hundreds of residents attended a free health fair at St. Columban Church. The Mobile Research Unit was at the event and had a record of 55 screenings while sharing the importance of brain health. To read the article in Vietnamese from […]
Breaking Barriers: New Findings on Biomarkers and Expanding Participation in Alzheimer’s Research
GAP Experts Share Poster Presentations at Alzheimer’s Association International Conference (AAIC) Washington D.C., July 9, 2026- The Global Alzheimer’s Platform Foundation®, (GAP) will have two poster presentations at the 2026 Alzheimer’s Association International Conference (AAIC) being held in Londong July 12 through July 15. All posters are in the Exhibit Hall in Excel London, Royal Victoria Dock, 1 […]
Global Alzheimer’s Platform Foundation Announces Strategic Partnership with Taudia for the Transformative Bio-Hermes-002 Study
Bio-Hermes-002 is a collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer’s disease and dementias Washington D.C., July 8, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Taudia to the Bio-Hermes-002 study, a unique observational platform study, which evaluates blood-based and digital biomarkers across a wide spectrum of […]
GAP’s 2026 Q2 Highlights
Colleagues, Partners & Friends, As we look forward to seeing many of you at the 2026 Alzheimer’s Association International Conference in London, I look back with pride on the Global Alzheimer’s Platform Foundation’s (GAP) Q2 performance. Our Trial Execution Services (TES) (GAP Participant Services and Inclusive Research Initiative®) teams collectively supported 120 GAP-Net site events […]
Norway Sun: “Global Study Develops Convenient Blood Test for Alzheimer’s”
By:Ingrid Johansen, Date: July 7, 2026 A significant global research initiative is underway to develop a convenient blood test for diagnosing Alzheimer’s disease. The study focuses on three specific proteins linked to the condition, aiming to compare the efficacy of the test with current brain scans. If successful, this new test could offer a simpler […]
GAP Applauds the Decision by Elevance Health to Explicitly Endorse the Use of Blood-Based Biomarker Testing
Washington D.C., July 1, 2026- Elevance Health, formerly Anthem Inc., updated their medical policy, to allow for blood-based biomarker testing for the detection and diagnosis of Alzheimer’s disease, making Elevance Health one of the first major payors to outline coverage criteria. GAP President John Dwyer said, “GAP applauds the decision by Elevance Health to explicitly endorse […]
TrialSite News: Exploring Circular RNA Biomarkers in Alzheimer’s Research
John Dwyer, the President of the Global Alzheimer’s Platform Foundation (GAP) joins TrialSiteNews to discuss a collaboration and partnership with Circular Genomics. The partnership will analyze blood test samples to investigate the potential for circular RNA biomarkers to assist in the diagnosis & treatment of Alzheimer’s Disease. Topics covered: Press Release: https://globalalzplatform.org/2026/05…